Pharmeca.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Egis Pharmaceuticals PLC, against the decision of the State Institute for Drug Control from 14. 6. 2019, under the no.: SUKLS67945/2019:

• the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Biogen Netherlands B. V., against the decision of the State Institute for Drug Control from 18. 6. 2019, under the no.: SUKLS233890/2018:

• the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant AstraZeneca AB, against the decision of the State Institute for Drug Control from 24. 6. 2019, under the no. SUKLS51736/2013:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
  

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of health insurance companies, against the decision of the State Institute for Drug Control from 17. 6. 2019, under the no. SUKLS1852/2019:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
  

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Janssen-Cilag International N.V., against the decision of the State Institute for Drug Control from 11. 3. 2021, under the no.: SUKLS46933/2021:

• the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of health insurance companies, against the decision of the State Institute for Drug Control from 25. 3. 2019, under the no. SUKLS485/2018:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
  

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelants Janssen-Cilag International N.V. and GlaxoSmithKline (Ireland) Limited, against the decision of the State Institute for Drug Control from 31. 5. 2019, under the no.: SUKLS312679/2018:

• the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Menarini International Operations Luxembourg S.A., against the decision of the State Institute for Drug Control from 9. 12. 2020, under the no. SUKLS306022/2020:

• under article 90 paragraph 1 of the Administative Code the decision under appeal is dismissed and the proceedings are terminated.

More information: MZCR.cz.

Published 10. 6. 2021.